Vecuronium is more potent in Montreal than in Paris
- PMID: 1680573
- DOI: 10.1007/BF03008448
Vecuronium is more potent in Montreal than in Paris
Abstract
This study was undertaken to compare the potency of vecuronium in patients anaesthetized in Montreal or Paris. Anaesthesia was induced with thiopentone and maintained with N2O, and intermittent boluses of thiopentone and fentanyl in 18 patients in Paris and 19 in Montreal. Neuromuscular blockade was measured using train-of-four stimulation of the ulnar nerve. The force of contraction of the adductor pollicis muscle was measured. Single doses of vecuronium, 20, 30, or 40 micrograms.kg-1 were given by random allocation. Dose response curves were constructed by obtaining the linear regression of the logit of the first response (T1) neuromuscular blockade versus log dose. The patients in Paris required 27% more vecuronium (95% confidence limits 5-53%; P = 0.01) for the same intensity of blockade. In Montreal, the ED50 and ED90 (+/- SEE for the mean) values were 26.0 +/- 1.4 and 44.2 +/- 2.5 micrograms.kg-1 compared with 33.0 +/- 3.3 and 71.9 +/- 7.2 micrograms.kg-1 in Paris respectively. The patients were comparable with respect to age, sex, height and weight. These results confirm, for vecuronium, the transatlantic difference in potency of neuromuscular blocking drugs which was previously observed with d-tubocurarine between London and New York.
Similar articles
-
Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.Can J Anaesth. 1994 Oct;41(10):908-12. doi: 10.1007/BF03010933. Can J Anaesth. 1994. PMID: 8001209
-
Nitrous oxide potentiates vecuronium neuromuscular blockade in humans.Can J Anaesth. 1991 Oct;38(7):866-9. doi: 10.1007/BF03036961. Can J Anaesth. 1991. PMID: 1683819 Clinical Trial.
-
Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism.Can J Anaesth. 1994 Aug;41(8):694-8. doi: 10.1007/BF03015623. Can J Anaesth. 1994. PMID: 7923517 Clinical Trial.
-
Potency of atracurium and vecuronium at the diaphragm and the adductor pollicis muscle.Br J Anaesth. 1988 Sep;61(3):286-91. doi: 10.1093/bja/61.3.286. Br J Anaesth. 1988. PMID: 2902872
-
[The dose-response relationship and time course of the neuromuscular blockade by alcuronium].Anaesthesist. 1990 Oct;39(10):508-12. Anaesthesist. 1990. PMID: 1980578 German.
Cited by
-
Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.Can J Anaesth. 1994 Oct;41(10):908-12. doi: 10.1007/BF03010933. Can J Anaesth. 1994. PMID: 8001209
-
First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2.Br J Anaesth. 2021 May;126(5):949-957. doi: 10.1016/j.bja.2021.01.029. Epub 2021 Mar 4. Br J Anaesth. 2021. PMID: 33676726 Free PMC article.
-
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.Korean J Anesthesiol. 2013 Dec;65(6):501-7. doi: 10.4097/kjae.2013.65.6.501. Epub 2013 Dec 26. Korean J Anesthesiol. 2013. PMID: 24427455 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources